squamous cell cancer of the head and neck

February 14, 2018February 14, 2018

Phase 2 Trial to Evaluate Combo of Imprime PGG, Keytruda in Head and Neck Cancer

News

Biothera Pharmaceuticals has begun treating patients in a Phase 2 clinical trial evaluating its Imprime PGG in combination with Merck’s Keytruda (pembrolizumab) for patients with advanced squamous cell carcinoma of ... Read more

March 29, 2017March 29, 2017

CHMP Recommends Opdivo Be Approved in EU to Treat Head and Neck Squamous Cell Cancer

News

The Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency, has issued a positive opinion that recommends Opdivo (nivolumab) be approved to treat people with squamous cell ... Read more